Ruptured abdominal aortic aneurysm: lower mortality with endovascular treatment at an experienced center.

Original title: Mortality from ruptured abdominal aortic aneurysms: clinical lessons from a comparison of outcomes in England and the USA. Reference: Karthikesalingam A et al. Lancet. 2014;383:963-969.

Treatment strategy for rAAA patients may vary according to the different centers. This study analyzed in-hospital mortality, and mortality after intervention of all patients admitted with rAAA between 2005 and 2010 in USA (n=23838) and compared outcomes with a similar population in England (n=11799). 

Global in-hospital mortality was lower in the USA than in England (53.05% vs. 65.9%; p<0.0001); however, looking into patients that received some kind of intervention, mortality was similar (41.7% vs 41.6%).

Interventions (conventional surgical or endovascular repair) were more frequent in USA than in England (80.4% vs 58.4%; p<0.001), as frequent were specifically endovascular interventions (20.8% vs 8.5%, p<0.0001). These differences persisted after aged matched and sex matched comparisons.

In both countries, mortality decreased with endovascular treatment. Center experience in endovascular repair and weekday admission were also predictors of lower mortality.

Conclusion

In-hospital survival and intervention rates (especially endovascular) are lower in England than in USA for patients admitted with rAAA. Patients that received endovascular treatment saw lower mortality rates.

Editorial Comment

The absence of follow up beyond hospital discharge is a limitation to this study, as it is the lack of data on anatomical characteristics or clinical status in deciding between conventional surgical strategy vs. endovascular repair with prosthesis.

As in most cases, prevention with a relatively simple screening to allow programmed treatment would greatly reduce mortality for AAA and save the efforts it requires once ruptured. In the event of rupture, the best strategy to reduce mortality seems to be endovascular treatment in an experienced center.

SOLACI.ORG

More articles by this author

ACC 2026 | HI-PEITHO: Catheter-directed strategy (EKOS) in intermediate-risk acute pulmonary embolism

The treatment of intermediate-risk pulmonary embolism (PE) continues to be an area of therapeutic uncertainty. The initial PEITHO study (2014) demonstrated a reduction in...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

FFR Assessment for the Selection of Hypertensive Patients Who Benefit from Renal Stenting

Atherosclerotic renal artery stenosis (ARAS) represents one of the main causes of secondary hypertension (HTN) and is associated with a higher risk of renal...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

Ischemic stroke remains one of the most feared complications of TAVI, with a relatively low but persistent incidence of 2–4%, without significant reduction over...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...